Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study

İnal, AliIşıkdoğan, AbdurrahmanKoş, F. TuğbaAlgın, EfnanGümüş, MahmutDikilitaş, MustafaElkıran, Emin Tamer2020-03-262020-03-2620110732-183X1527-7755https://dx.doi.org/10.1200/jco.2011.29.15_suppl.e14534https://hdl.handle.net/20.500.12395/26516[Abstract not Available]en10.1200/jco.2011.29.15_suppl.e14534info:eu-repo/semantics/closedAccessGemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter studyConference Object2915WOS:000208880303588Q1